Pathstone Family Office’s Steris STE Stock Holding History
Bought
Maintained
Sold
Other funds holding STE
Pathstone Family Office's STE Position: Q3 2023 in Review
Pathstone Family Office increased its Steris (STE) stake by 47% in Q3 2023, buying an estimated $573K and bringing the position to 7,904 shares worth $1.73M. The position accounts for 0.01% of the portfolio, ranked #501.
Pathstone Family Office first reported a position in STE in Q1 2018 and has held it in 14 quarters since. The position peaked at $2.65M in Q3 2022. 682 funds tracked by Wall St. Rank hold STE as of Q3 2023.
- Pathstone Family Office held 7,904 shares of Steris worth $1.73M as of Q3 2023.
- Pathstone Family Office bought 2,531 Steris shares in Q3 2023, an estimated $573K.
- Steris made up 0.01% of Pathstone Family Office's portfolio in Q3 2023, its #501 holding.
- Pathstone Family Office first reported a position in Steris in Q1 2018 and has held it in 14 quarters since.
- Pathstone Family Office's Steris position peaked at $2.65M in Q3 2022.
- 682 funds tracked by Wall St. Rank held Steris as of Q3 2023.
Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.